Suppr超能文献

两种新型苯并恶唑和苯并噻唑衍生物的SNS供体钯(II)配合物作为潜在的抗癌剂。

Two novel SNS-donor palladium(II) complexes of benzoxazole and benzothiazole derivatives as potential anticancer agents.

作者信息

Ma Xiaomeng, Xie Yuting, Tang Jiazhen, Xue Jian, Chen Zhanfen

机构信息

Key Laboratory of Optoelectronic Chemical Materials and Devices of Ministry of Education, School of Optoelectronic Materials and Technologies, Jianghan University, Wuhan 430056, P. R. China.

出版信息

Dalton Trans. 2025 Jan 21;54(4):1677-1688. doi: 10.1039/d4dt02684e.

Abstract

Two novel mononuclear palladium(II) complexes, [PdL1Cl]Cl (1) and [PdL2Cl]Cl (2) with SNS-donor ligands [where L1 = -(4-(benzo[]oxazol-2-yl)phenyl)-2-(bis(2-ethylthioethyl)amino)acetamide, L2 = -(4-(benzo[]thiazol-2-yl)phenyl)-2-(bis(2-ethylthioethyl)amino)acetamide], were synthesized and characterized. antiproliferative activity tests showed that the two palladium(II) complexes displayed excellent antiproliferative activity against all tested cancer cell lines, especially human colon cancer HCT-116, human liver cancer HepG-2, and human breast cancer MDA-MB-231 cells. Spectacularly, complexes 1 and 2 exhibited approximately 8.49- and 6.88-fold higher antiproliferative activity, as compared with cisplatin, against HCT-116, respectively, but were less toxic to human normal colon fibroblast CCD-18Co cell lines with selectivity index (SI = IC(CCD-18Co)/IC(HCT-116)) values of 22.43 and 21.48 for 1 and 2, respectively, compared to that of cisplatin (SI, 1.74). These results suggested that the two palladium complexes have the potential to act as candidates for the treatment of colorectal cancer. The interaction of the complexes with CT-DNA and pUC19 plasmid DNA illustrated that both 1 and 2 could strongly bind to the DNA helix an intercalative mode and covalent interaction and perturb the tertiary structure of DNA, where the DNA binding affinity of 1 was slightly higher than that of 2. Additionally, investigations of the reaction of the two complexes with 5'-GMP and glutathione (GSH) showed that both 1 and 2 could readily react with 5'-GMP and GSH to form Pd-GMP adducts and Pd-GS adducts, respectively, and when 5'-GMP and GSH coexisted, the coordination binding of the complexes with GSH did not prevent the formation of the Pd-GMP adducts. Moreover, Hoechst 33342 staining and flow cytometry analysis demonstrated that the two palladium(II) complexes arrested HCT-116 cells mainly at the G2/M phase, induced mitochondrial-membrane depolarization, increased ROS generation, and triggered obvious cell apoptosis.

摘要

合成并表征了两种新型单核钯(II)配合物,[PdL1Cl]Cl(1)和[PdL2Cl]Cl(2),它们带有SNS供体配体[其中L1 = -(4-(苯并[ ]恶唑-2-基)苯基)-2-(双(2-乙硫基乙基)氨基)乙酰胺,L2 = -(4-(苯并[ ]噻唑-2-基)苯基)-2-(双(2-乙硫基乙基)氨基)乙酰胺]。抗增殖活性测试表明,这两种钯(II)配合物对所有测试的癌细胞系均表现出优异的抗增殖活性,尤其是对人结肠癌细胞HCT-116、人肝癌细胞HepG-2和人乳腺癌细胞MDA-MB-231。特别地,与顺铂相比,配合物1和2对HCT-116的抗增殖活性分别高出约8.49倍和6.88倍,但对人正常结肠成纤维细胞CCD-18Co细胞系的毒性较小,配合物1和2的选择性指数(SI = IC(CCD-18Co)/IC(HCT-116))值分别为22.43和21.48,而顺铂的选择性指数为1.74。这些结果表明,这两种钯配合物有潜力作为治疗结直肠癌的候选药物。配合物与CT-DNA和pUC19质粒DNA的相互作用表明,1和2均可通过插入模式和共价相互作用与DNA螺旋强烈结合并扰乱DNA的三级结构,其中1与DNA的结合亲和力略高于2。此外,对这两种配合物与5'-GMP和谷胱甘肽(GSH)反应的研究表明,1和2均可分别与5'-GMP和GSH轻松反应形成Pd-GMP加合物和Pd-GS加合物,并且当5'-GMP和GSH共存时,配合物与GSH的配位结合并不妨碍Pd-GMP加合物的形成。此外,Hoechst 33342染色和流式细胞术分析表明,这两种钯(II)配合物主要将HCT-116细胞阻滞在G2/M期,诱导线粒体膜去极化,增加ROS生成,并引发明显的细胞凋亡。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验